Is Trillium Therapeutics Canadian?
No
This brand is owned by a foreign parent company.
What we found
Trillium Therapeutics was a Canadian immuno-oncology company (CD47-targeting cancer therapies, rooted in Toronto's UHN/SickKids research ecosystem) that Pfizer fully acquired in a deal completed November 17, 2021 for rou.
The receipt
| Verdict | Foreign-owned |
| Category | Biotech & Life Sciences |
| HQ | Toronto, Ontario |
| Confidence | high |
| Evidence | Government registry / filing |
| Source | https://www.wikidata.org/wiki/Q30292382 registry record “SEC EDGAR 10-K filed 2026-03-09 by ALX ONCOLOGY HOLDINGS INC names Trillium Therapeutics — parent company's own annual filing.” |
Canadian alternatives to Trillium Therapeutics
Every brand below is listed as Canadian-owned in our registry.
| Brand | Category | HQ Location | Ownership Check |
|---|---|---|---|
| AbCellera Biologics | Biotech, Pharma & Life Sciences | Vancouver, BC | View ownership → |
| Aeterna Zentaris | Healthcare & Medical | Quebec City, QC | View ownership → |
| Cardiol Therapeutics | Biotech & Life Sciences | Oakville, Ontario | View ownership → |
| Kane Biotech | Biotech & Life Sciences | Winnipeg, Manitoba | View ownership → |
| Medicenna Therapeutics Corp. | Pharma & Healthcare Providers | Toronto, Ontario | View ownership → |
| Meditrope | Healthcare & Medical | Ontario | View ownership → |
Spotted something wrong? Ownership changes all the time — report a correction and we'll re-check the records.